ARQT R&D Expense Growth

Arcutis Biotherapeutics Inc · R&D Expense Growth

ARQT logo

ARQT R&D Expense Growth

Latest reported0.83%
ARQT FY R&D Growth (YoY) (0.00% → 0.83%)
High-resolution chart · PNG

ARQT r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcutis Biotherapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
0.8257%
-30.8885%
-39.3894%
25.3349%
26.2341%
215.722%
103.5786%
425.9455%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.